相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression
R. A. Hodgson et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal
Francesco Papaleo et al.
NEURON (2007)
Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats
Cindy K. Funk et al.
BIOLOGICAL PSYCHIATRY (2007)
The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress
Brook Henry et al.
JOURNAL OF NEUROSCIENCE (2006)
Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice
Francesco Papaleo et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Conditioned withdrawal drives heroin consumption and decreases reward sensitivity
Paul J. Kenny et al.
JOURNAL OF NEUROSCIENCE (2006)
Corticotropin-releasing factor receptor type 2-deficient mice display impaired coping behaviors during stress
SC Coste et al.
GENES BRAIN AND BEHAVIOR (2006)
The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal
A Contarino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Role of withdrawal in reinstatement of morphine-conditioned place preference
L Lu et al.
PSYCHOPHARMACOLOGY (2005)
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats
L Stinus et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Combating opiate dependence: a comparison among the available pharmacological options
G Gonzalez et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice
DM Nielsen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior
VB Risbrough et al.
JOURNAL OF NEUROSCIENCE (2004)
Increased anxiety-like behavior and ethanol self-administration in dependent rats: Reversal via corticotropin-releasing factor-2 receptor activation
GR Valdez et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2004)
Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo-pituitary-adrenal activity after withdrawal from intermittent morphine treatment
H Houshyar et al.
JOURNAL OF NEUROSCIENCE (2004)
Addiction motivation reformulated: An affective processing model of negative reinforcement
TB Baker et al.
PSYCHOLOGICAL REVIEW (2004)
Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: Modulation by stress and attenuation of some anxiety-like behaviours
M Venihaki et al.
JOURNAL OF NEUROENDOCRINOLOGY (2004)
Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress
MB Müller et al.
NATURE NEUROSCIENCE (2003)
Locornotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist
GR Valdez et al.
BRAIN RESEARCH (2003)
The reinstatement model of drug relapse: history, methodology and major findings
Y Shaham et al.
PSYCHOPHARMACOLOGY (2003)
International union of pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands
RL Hauger et al.
PHARMACOLOGICAL REVIEWS (2003)
Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice
VB Risbrough et al.
PSYCHOPHARMACOLOGY (2003)
Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat
EP Zorrilla et al.
BRAIN RESEARCH (2002)
Pharmacotherapy of addictions
MJ Kreek et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide
GR Valdez et al.
BRAIN RESEARCH (2002)
Gender-linked differences in the expression of physical dependence in the rat
TJ Cicero et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor1 receptor antagonist.: II.: Characterization in rodent models of stress-related disorders
G Griebel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Targeted mutations of the corticotropin-releasing factor system: effects on physiology and behavior
A Contarino et al.
NEUROPEPTIDES (2002)
Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor
SP Ho et al.
MOLECULAR BRAIN RESEARCH (2001)
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
TL Bale et al.
NATURE GENETICS (2000)
Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
T Kishimoto et al.
NATURE GENETICS (2000)
Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2
SC Coste et al.
NATURE GENETICS (2000)
分享论文
